- Home
- MDLZ vs ZTS Comparison
MDLZ vs ZTS Comparison
Compare MDLZ & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDLZ
- ZTS
- Stock Information
- Founded
- MDLZ 2000
- ZTS 1952
- Country
- MDLZ United States
- ZTS United States
- Employees
- MDLZ N/A
- ZTS N/A
- Industry
- MDLZ Packaged Foods
- ZTS Biotechnology: Pharmaceutical Preparations
- Sector
- MDLZ Consumer Staples
- ZTS Health Care
- Exchange
- MDLZ Nasdaq
- ZTS Nasdaq
- Market Cap
- MDLZ 82.0B
- ZTS 66.2B
- IPO Year
- MDLZ N/A
- ZTS 2013
- Fundamental
- Price
- MDLZ $62.67
- ZTS $146.42
- Analyst Decision
- MDLZ Buy
- ZTS Buy
- Analyst Count
- MDLZ 19
- ZTS 8
- Target Price
- MDLZ $71.68
- ZTS $200.25
- AVG Volume (30 Days)
- MDLZ 7.2M
- ZTS 3.0M
- Earning Date
- MDLZ 10-28-2025
- ZTS 11-04-2025
- Dividend Yield
- MDLZ 3.19%
- ZTS 1.37%
- EPS Growth
- MDLZ N/A
- ZTS 14.10
- EPS
- MDLZ 2.75
- ZTS 5.82
- Revenue
- MDLZ $37,105,000,000.00
- ZTS $9,385,000,000.00
- Revenue This Year
- MDLZ $7.91
- ZTS $3.90
- Revenue Next Year
- MDLZ $4.57
- ZTS $5.92
- P/E Ratio
- MDLZ $22.79
- ZTS $25.16
- Revenue Growth
- MDLZ 3.14
- ZTS 5.27
- 52 Week Low
- MDLZ $53.95
- ZTS $139.34
- 52 Week High
- MDLZ $72.70
- ZTS $196.55
- Technical
- Relative Strength Index (RSI)
- MDLZ 48.98
- ZTS 46.66
- Support Level
- MDLZ $61.22
- ZTS $142.40
- Resistance Level
- MDLZ $63.33
- ZTS $149.54
- Average True Range (ATR)
- MDLZ 1.27
- ZTS 2.87
- MACD
- MDLZ -0.02
- ZTS 0.39
- Stochastic Oscillator
- MDLZ 38.87
- ZTS 69.41
About MDLZ Mondelez International Inc.
Mondelez has operated independently since its split from the former Kraft Foods North American grocery business in October 2012. The firm is a leading player in the global snack enclave with a presence in the biscuit (49% of sales as of the end of fiscal 2024), chocolate (31%), gum/candy (11%), beverage (3%), and cheese and grocery (6%) aisles. Mondelez's portfolio includes well-known brands like Oreo, Chips Ahoy, Halls, and Cadbury. The firm derives around one-third of its revenue from developing markets, just more than one-third from Europe, and the remainder from North America.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.